Cargando…

Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait

INTRODUCTION: Coordinated Reset Deep Brain Stimulation (CR DBS) is a novel DBS approach for treating Parkinson's disease (PD) that uses lower levels of burst stimulation through multiple contacts of the DBS lead. Though CR DBS has been demonstrated to have sustained therapeutic effects on rigid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosley, Kai M., Luo, Ziling, Amoozegar, Sana, Acedillo, Kit, Nakajima, Kanon, Johnson, Luke A., Vitek, Jerrold L., Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483836/
https://www.ncbi.nlm.nih.gov/pubmed/37692361
http://dx.doi.org/10.3389/fninf.2023.1185723
_version_ 1785102470423248896
author Bosley, Kai M.
Luo, Ziling
Amoozegar, Sana
Acedillo, Kit
Nakajima, Kanon
Johnson, Luke A.
Vitek, Jerrold L.
Wang, Jing
author_facet Bosley, Kai M.
Luo, Ziling
Amoozegar, Sana
Acedillo, Kit
Nakajima, Kanon
Johnson, Luke A.
Vitek, Jerrold L.
Wang, Jing
author_sort Bosley, Kai M.
collection PubMed
description INTRODUCTION: Coordinated Reset Deep Brain Stimulation (CR DBS) is a novel DBS approach for treating Parkinson's disease (PD) that uses lower levels of burst stimulation through multiple contacts of the DBS lead. Though CR DBS has been demonstrated to have sustained therapeutic effects on rigidity, tremor, bradykinesia, and akinesia following cessation of stimulation, i.e., carryover effect, its effect on Parkinsonian gait has not been well studied. Impaired gait is a disabling symptom of PD, often associated with a higher risk of falling and a reduced quality of life. The goal of this study was to explore the carryover effect of subthalamic CR DBS on Parkinsonian gait. METHODS: Three non-human primates (NHPs) were rendered Parkinsonian and implanted with a DBS lead in the subthalamic nucleus (STN). For each animal, STN CR DBS was delivered for several hours per day across five consecutive days. A clinical rating scale modified for NHP use (mUPDRS) was administered every morning to monitor the carryover effect of CR DBS on rigidity, tremor, akinesia, and bradykinesia. Gait was assessed quantitatively before and after STN CR DBS. The stride length and swing speed were calculated and compared to the baseline, pre-stimulation condition. RESULTS: In all three animals, carryover improvements in rigidity, bradykinesia, and akinesia were observed after CR DBS. Increased swing speed was observed in all the animals; however, improvement in stride length was only observed in NHP B2. In addition, STN CR DBS using two different burst frequencies was evaluated in NHP B2, and differential effects on the mUPDRS score and gait were observed. DISCUSSION: Although preliminary, our results indicate that STN CR DBS can improve Parkinsonian gait together with other motor signs when stimulation parameters are properly selected. This study further supports the continued development of CR DBS as a novel therapy for PD and highlights the importance of parameter selection in its clinical application.
format Online
Article
Text
id pubmed-10483836
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104838362023-09-08 Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait Bosley, Kai M. Luo, Ziling Amoozegar, Sana Acedillo, Kit Nakajima, Kanon Johnson, Luke A. Vitek, Jerrold L. Wang, Jing Front Neuroinform Neuroscience INTRODUCTION: Coordinated Reset Deep Brain Stimulation (CR DBS) is a novel DBS approach for treating Parkinson's disease (PD) that uses lower levels of burst stimulation through multiple contacts of the DBS lead. Though CR DBS has been demonstrated to have sustained therapeutic effects on rigidity, tremor, bradykinesia, and akinesia following cessation of stimulation, i.e., carryover effect, its effect on Parkinsonian gait has not been well studied. Impaired gait is a disabling symptom of PD, often associated with a higher risk of falling and a reduced quality of life. The goal of this study was to explore the carryover effect of subthalamic CR DBS on Parkinsonian gait. METHODS: Three non-human primates (NHPs) were rendered Parkinsonian and implanted with a DBS lead in the subthalamic nucleus (STN). For each animal, STN CR DBS was delivered for several hours per day across five consecutive days. A clinical rating scale modified for NHP use (mUPDRS) was administered every morning to monitor the carryover effect of CR DBS on rigidity, tremor, akinesia, and bradykinesia. Gait was assessed quantitatively before and after STN CR DBS. The stride length and swing speed were calculated and compared to the baseline, pre-stimulation condition. RESULTS: In all three animals, carryover improvements in rigidity, bradykinesia, and akinesia were observed after CR DBS. Increased swing speed was observed in all the animals; however, improvement in stride length was only observed in NHP B2. In addition, STN CR DBS using two different burst frequencies was evaluated in NHP B2, and differential effects on the mUPDRS score and gait were observed. DISCUSSION: Although preliminary, our results indicate that STN CR DBS can improve Parkinsonian gait together with other motor signs when stimulation parameters are properly selected. This study further supports the continued development of CR DBS as a novel therapy for PD and highlights the importance of parameter selection in its clinical application. Frontiers Media S.A. 2023-08-24 /pmc/articles/PMC10483836/ /pubmed/37692361 http://dx.doi.org/10.3389/fninf.2023.1185723 Text en Copyright © 2023 Bosley, Luo, Amoozegar, Acedillo, Nakajima, Johnson, Vitek and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Bosley, Kai M.
Luo, Ziling
Amoozegar, Sana
Acedillo, Kit
Nakajima, Kanon
Johnson, Luke A.
Vitek, Jerrold L.
Wang, Jing
Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait
title Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait
title_full Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait
title_fullStr Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait
title_full_unstemmed Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait
title_short Effect of subthalamic coordinated reset deep brain stimulation on Parkinsonian gait
title_sort effect of subthalamic coordinated reset deep brain stimulation on parkinsonian gait
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483836/
https://www.ncbi.nlm.nih.gov/pubmed/37692361
http://dx.doi.org/10.3389/fninf.2023.1185723
work_keys_str_mv AT bosleykaim effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT luoziling effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT amoozegarsana effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT acedillokit effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT nakajimakanon effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT johnsonlukea effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT vitekjerroldl effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait
AT wangjing effectofsubthalamiccoordinatedresetdeepbrainstimulationonparkinsoniangait